Impact of Conversion From Pegylated Interferon-α2b to Interferon-α2a for Treating Recurrent Hepatitis C After Liver Transplantation-Reference-Cited by-同舟云学术

Impact of Conversion From Pegylated Interferon-α2b to Interferon-α2a for Treating Recurrent Hepatitis C After Liver Transplantation

Published:2013-03-27 Issue:6 Volume:95 Page:e38-e42
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Ikegami Toru,Shirabe Ken,Yoshizumi Tomoharu,Furusyo Norihiro,Kotoh Kazuhiro,Kato Masaki,Shimoda Shinji,Soejima Yuji,Motomura Takashi,Fukuhara Takasuke,Maehara Yoshihiko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. . Peginterferon alpha-2a is associated with higher sustained virological response than Peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials.;Awad;Hepatology,2010

2. . Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.;Glue;Clin Pharmacol Ther,2000

3. . Peginterferon alfa-2a plus ribavirin is more effective than Peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection.;Ascione;Gastroenterology,2010

4. . Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension.;Ikegami;J Am Coll Surg,2009

5. . Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.;Ikegami;Transplantation,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of hepatitis C infection before and after liver transplantation;World Journal of Gastroenterology;2015-04-21

2. Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C;Hepatology International;2013-12-27